---
search:
  boost: 2 
---

# Topical Acne Products

This is a subcategory of Central Nervous System (CNS) Agents.

## Formulary

### Preferred

| Preferred                               | Generic Name | Quantity | Time (Days) |
| :-------------------------------------- | :----------- | :------: | :---------: |
| Adapalene Gel 0.1% <sup>AR</sup>        |              |          |             |
| Azelex Cream                            |              |          |             |
| Benzoyl Peroxide                        |              |          |             |
| Clindamycin Gel                         |              |          |             |
| Clindamycin Lot                         |              |          |             |
| Clindamycin Sol                         |              |          |             |
| Clindamycin / Benzoyl Peroxide          |              |          |             |
| Erythromycin                            |              |          |             |
| Erythromycin / Benzoyl Peroxide         |              |          |             |
| Neuac                                   |              |          |             |
| Sodium Sulfacetamide                    |              |          |             |
| Sodium Sulfacetamide / Sulfur Cream     |              |          |             |
| Sodium Sulfacetamide / Sulfur Wash Susp |              |          |             |
| Tretinoin <sup>AR</sup>                 |              |          |             |

### Non-Preferred

| Non-Preferred                            | Generic Name | Quantity | Time (Days) |
| :--------------------------------------- | :----------- | :------: | :---------: |
| Adapalene Cream, Sol 0.1% <sup>AR</sup>  |              |          |             |
| Adapalene Gel 0.3% <sup>AR</sup>         |              |          |             |
| Adapalene/Benzoyl Peroxide <sup>AR</sup> |              |          |             |
| Aklief <sup>AR</sup>                     |              |          |             |
| Altreno <sup>AR</sup>                    |              |          |             |
| Amzeeq                                   |              |          |             |
| Arazlo <sup>AR</sup>                     |              |          |             |
| Azelaic Acid Gel                         |              |          |             |
| Benzoyl Peroxide Foam                    |              |          |             |
| Clindacin Kit                            |              |          |             |
| Clindamycin Foam                         |              |          |             |
| Clindamycin Swabs                        |              |          |             |
| Clindamycin / Tretinoin <sup>AR</sup>    |              |          |             |
| Dapsone Gel                              |              |          |             |
| Finacea Foam                             |              |          |             |
| Onexton Gel                              |              |          |             |
| Ovace Plus                               |              |          |             |
| Plixda <sup>AR</sup>                     |              |          |             |
| Sodium Sulfacetamide / Sulfur Gel        |              |          |             |
| Sodium Sulfaetamide Pads                 |              |          |             |
| Tazarotene Cream 0.1% <sup>AR</sup>      |              |          |             |
| Tazarotene Foam 0.1% <sup>AR</sup>       |              |          |             |
| Twyneo <sup>AR</sup>                     |              |          |             |
| Winlevi                                  |              |          |             |

## Length of Authorizations

365 Days

**All Authorizations**

Must be prescribed in accordance with FDA approved labeling

## Additonal Criteria

### Non-Preferred

-   Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    -   For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
-   Must have had an inadequate clinical response of at least **30 days** (or **90 days** for retinoids) of at least **three preferred** drugs
    -   For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    -   For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

### Tretinoin/Benzoyl Peroxide

Additional Tretinoin/Benzoyl Peroxide (Twyneo) Criteria

-   Must provide documentation for patient’s inability to use the individual drugs

### Additional Information

-   All retinoids – May be authorized with a diagnosis of skin cancer
-   Tazarotene (Tazorac) – May be authorized with a diagnosis or psoriasis

### Subsequent Authorization

-   Must provide documentation of patient’s clinical response to treatment and ongoing safety monitoring

**AR**- All topical retinoids: a PA is required for patients 24 years and older

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_UPDL%20_Criteria_APPROVED.pdf#page=50)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_UPDL_APPROVED_12.13.22.pdf#page=19)

[Quantity Limit List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf)
